Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06578182

The Effect of ColcHicine on the Incidence of Knee or Hip Replacements

The Effect of ColcHicine on the Incidence of Knee or Hip Replacements: a Randomized, Double-blind, Multicentre Study in Symptomatic Knee or Hip Osteoarthritis

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
1,410 (estimated)
Sponsor
Sint Maartenskliniek · Academic / Other
Sex
All
Age
45 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate the effect of treatment with colchicine 0.5mg once daily as compared to placebo in patients with knee or hip osteoarthritis on the incidence of first occurrence of knee or hip replacement. The main question it aims to answer is: Does colchicine lower the number of knee or hip replacements in participants with osteoarthritis? Researchers will compare colchicine to a placebo (a look-alike substance that contains no drug) to see if colchicine works to treat osteoarthritis. Participants will: * take colchicine every day for 3 tot 4.5 years * visit the clinic every year for check-up and tests such as blood samples and x-rays * fill in questionnaires every 3 months

Conditions

Interventions

TypeNameDescription
DRUGColchicineColchicine 0.5mg tablets once a day for 3 to 4.5 years
DRUGPlaceboPlacebo tablets once a day for 3 to 4.5 years

Timeline

Start date
2025-01-01
Primary completion
2029-03-31
Completion
2029-03-31
First posted
2024-08-29
Last updated
2025-02-20

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06578182. Inclusion in this directory is not an endorsement.